| The role of the European Chemicals Bureau in promoting the regulatory use of (Q) SAR methods AP Worth, A Bassan, J De Bruijn, A Gallegos Saliner, T Netzeva, M Pavan, ... SAR and QSAR in Environmental Research 18 (1-2), 111-125, 2007 | 134 | 2007 |
| The characterisation of (quantitative) structure-activity relationships: preliminary guidance AP Worth, A Bassan, A Gallegos, TI Netzeva, G Patlewicz, M Pavan, ... Institute for Health and Consumer Protection, Toxicology and Chemical …, 2005 | 84 | 2005 |
| Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens R Benigni, C Bossa, T Netzeva, A Rodomonte, I Tsakovska Environmental and molecular mutagenesis 48 (9), 754-771, 2007 | 75 | 2007 |
| Interactions of poly (vinylpyrrolidone) with ibuprofen and naproxen: experimental and modeling studies S Bogdanova, I Pajeva, P Nikolova, I Tsakovska, B Müller Pharmaceutical research 22 (5), 806-815, 2005 | 73 | 2005 |
| A mini review of mammalian toxicity (Q) SAR models I Tsakovska, I Lessigiarska, T Netzeva, AP Worth QSAR & Combinatorial Science 27 (1), 41-48, 2008 | 58 | 2008 |
| Computational studies of free radical-scavenging properties of phenolic compounds P Alov, I Tsakovska, I Pajeva Current topics in medicinal chemistry 15 (2), 85-104, 2015 | 56 | 2015 |
| Validation of counter propagation neural network models for predictive toxicology according to the OECD principles: a case study M Vračko, V Bandelj, P Barbieri, E Benfenati, Q Chaudhry, M Cronin, ... SAR and QSAR in Environmental Research 17 (3), 265-284, 2006 | 47 | 2006 |
| Molecular modelling study of the PPARγ receptor in relation to the mode of action/adverse outcome pathway framework for liver steatosis I Tsakovska, M Al Sharif, P Alov, A Diukendjieva, E Fioravanzo, ... International journal of molecular sciences 15 (5), 7651-7666, 2014 | 35 | 2014 |
| Quantitative structure-skin permeability relationships I Tsakovska, I Pajeva, M Al Sharif, P Alov, E Fioravanzo, S Kovarich, ... Toxicology 387, 27-42, 2017 | 33 | 2017 |
| QSAR and 3D-QSAR of phenothiazine type multidrug resistance modulators in P388/ADR cells IM Tsakovska Bioorganic & medicinal chemistry 11 (13), 2889-2899, 2003 | 33 | 2003 |
| Modes-of-action related to repeated dose toxicity: Tissue-specific biological roles of PPARγ ligand-dependent dysregulation in nonalcoholic fatty liver disease M Al Sharif, P Alov, V Vitcheva, I Pajeva, I Tsakovska PPAR research 2014, 2014 | 24 | 2014 |
| Evaluation of SARs for the prediction of skin irritation/corrosion potential–structural inclusion rules in the BfR decision support system A Gallegos Saliner, I Tsakovska, M Pavan, G Patlewicz, AP Worth SAR and QSAR in Environmental Research 18 (3-4), 331-342, 2007 | 22 | 2007 |
| Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance I Tsakovska, I Pajeva Current drug targets 7 (9), 1123-1134, 2006 | 22 | 2006 |
| Evaluation of SARs for the prediction of eye irritation/corrosion potential–structural inclusion rules in the BfR decision support system I Tsakovska, AG Saliner, T Netzeva, M Pavan, AP Worth SAR and QSAR in Environmental Research 18 (3-4), 221-235, 2007 | 18 | 2007 |
| The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation M Al Sharif, I Tsakovska, I Pajeva, P Alov, E Fioravanzo, A Bassan, ... Toxicology 392, 140-154, 2017 | 17 | 2017 |
| Structural and dynamical insight into PPARγ antagonism: in silico study of the ligand-receptor interactions of non-covalent antagonists F Fratev, I Tsakovska, M Al Sharif, E Mihaylova, I Pajeva International journal of molecular sciences 16 (7), 15405-15424, 2015 | 14 | 2015 |
| Recent advances in the molecular modeling of estrogen receptor-mediated toxicity I Tsakovska, I Pajeva, P Alov, A Worth Advances in protein chemistry and structural biology 85, 217-251, 2011 | 14 | 2011 |
| Review of (Q) SARs for mammalian toxicity I Tsakovska, I Lessigiarska, T Netzeva, A Worth JRC report EUR 22846, 2006 | 13 | 2006 |
| Molecular modeling of P-glycoprotein and related drugs I Pajeva, C Globisch, R Fleischer, I Tsakovska, M Wiese Medicinal Chemistry Research 2 (14), 106-117, 2005 | 13 | 2005 |
| Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors S Dallavalle, V Dobričić, L Lazzarato, E Gazzano, M Machuqueiro, ... Drug Resistance Updates 50, 100682, 2020 | 10 | 2020 |
Ilza PajevaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of SciencesVerified email at biomed.bas.bg
